Van Eck Associates Corp Brainstorm Cell Therapeutics Inc. Transaction History

Van Eck Associates Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$3.01 - $4.01 $31,436 - $41,880	-10,444 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.46 - $7.88 $532 - $1,213	154 Added 1.5%	10,444 $40,000
Q4 2020 Feb 09, 2021	BUY	$3.99 - $17.73 $9,380 - $41,683	2,351 Added 29.61%	10,290 $47,000
Q3 2020 Dec 04, 2020	BUY	$11.19 - $16.92 $88,837 - $134,327	7,939 New	7,939 $134,000
Q3 2020 Nov 12, 2020	SELL	$11.19 - $16.92 $86,979 - $131,519	-7,773 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$4.42 - $12.66 $34,356 - $98,406	7,773 New	7,773 $87,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.